Literature DB >> 26655816

Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions.

Mert Ulaş Barut1, Ahmet Kale2, Umur Kuyumcuoğlu3, Murat Bozkurt4, Elif Ağaçayak3, Server Özekinci5, Talip Gül3.   

Abstract

BACKGROUND This study aimed to examine the positive and negative predictive value in the diagnosis of premalignant and malignant lesions of cervical colposcopy, the sensitivity and specificity of smear, and to evaluate the correlation with histopathology of abnormal cytology and colposcopy. MATERIAL AND METHODS The criteria for inclusion of patients with unhealthy cervix in the study were: Erosion, Chronic cervicitis, and Healed lacerations, Hypertrophied cervix, bleeding on touch, suspicious growth/ulcer/polyp on the cervix, and abnormal discharges from the cervix. Women with frank carcinoma cervix, pregnant females, patients with bleeding per vaginum at the time of examination, and those who had used vaginal medications, vaginal contraceptives or douches in the last 48 h of examination were excluded from the study. Demographic analysis was performed for 450 patients who were admitted to the clinic. Sensitivity, specificity, positive predictive value and negative predictive values of patients to identify cervical pathologies of smear and colposcopy were histopathologically calculated. The statistical software package SPSS 15.0 (SPSS Inc., Chicago, IL, USA) and Spearman's and Chi-Square tests were used for statistical analysis. RESULTS Sensitivity, specificity, PPD and NDP of smear were 0.57%, 0.76%, 0.26%, 0.92% respectively. Sensitivity, specificity, PPD and NDP of colposcopy were 0.92%, 0.67%, 0.52%, 0.96% respectively. A statistically significant correlation was found between abnormal cytology and histopathology, and abnormal colposcopy finding and histopathology. CONCLUSIONS Women with clinical diagnosis of unhealthy cervix should be evaluated by cytology to detect any premalignant or malignant lesions. It was concluded that Pap smear, colposcopy and histopathology should be collectively evaluated to evaluate cervical findings in low socio-economic regions.

Entities:  

Mesh:

Year:  2015        PMID: 26655816      PMCID: PMC4678924          DOI: 10.12659/msm.895227

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  16 in total

1.  [Cytologic correlation between the Bethesda system and colposcopic biopsy].

Authors:  J L González Sánchez; C Pérez Guerrero; G Celorio Aguilera; J Chávez Barambila; F A Ríos Montiel
Journal:  Ginecol Obstet Mex       Date:  1998-08

2.  Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.

Authors:  Viola M J Verhoef; Daniëlle A M Heideman; Folkert J van Kemenade; Lawrence Rozendaal; Remko P Bosgraaf; Albertus T Hesselink; Ruud L M Bekkers; Leon F A G Massuger; Renske D M Steenbergen; Peter J F Snijders; Johannes Berkhof; Chris J L M Meijer
Journal:  Gynecol Oncol       Date:  2014-08-08       Impact factor: 5.482

3.  Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

Authors:  R J Kurman; D E Henson; A L Herbst; K L Noller; M H Schiffman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

4.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 5.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

6.  Negative colposcopic biopsy after positive human papilloma virus (HPV) DNA testing: false-positive HPV results or false-negative histologic findings?

Authors:  Amy L Adams; Isam Eltoum; Janie Roberson; Jun Chen; Kathy Connolly; David C Chhieng
Journal:  Am J Clin Pathol       Date:  2006-03       Impact factor: 2.493

7.  A modified terminology for cervical intraepithelial neoplasia.

Authors:  R M Richart
Journal:  Obstet Gynecol       Date:  1990-01       Impact factor: 7.661

8.  Comparative study of cytologic and colposcopic findings in preclinical cervical cancer.

Authors:  A M Maziah; N A Sharifah; A Yahya
Journal:  Malays J Pathol       Date:  1991-12       Impact factor: 0.656

9.  [Cervical cytologic reports of ASCUS and LSIL. Cyto-histological correlation and implication for management].

Authors:  M G Fallani; C Penna; M Fambrini; M Marchionni
Journal:  Minerva Ginecol       Date:  2002-06

10.  Impact of colposcopy on management outcomes of patients with abnormal cervical cytology.

Authors:  R Koigi-Kamau; L W Kabare; J M Machoki
Journal:  East Afr Med J       Date:  2007-03
View more
  21 in total

1.  The relationship between the presence of HPV infection and biofilm formation in cervicovaginal smears.

Authors:  Hanife Guler Donmez; Gulcan Sahal; Utku Akgor; Murat Cagan; Nejat Ozgul; Mehmet Sinan Beksac
Journal:  Infection       Date:  2020-07-04       Impact factor: 3.553

2.  Comparison of HPV Testing and Colposcopy in Detecting Cervical Dysplasia in Patients With Cytological Abnormalities.

Authors:  Joanna Świderska-Kiec; Krzysztof Czajkowski; Julia Zaręba-Szczudlik; Joanna Kacperczyk-Bartnik; Paweł Bartnik; Ewa Romejko-Wolniewicz
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation.

Authors:  Natalia L Starodubtseva; Vitaliy V Chagovets; Maria E Nekrasova; Niso M Nazarova; Alisa O Tokareva; Olga V Bourmenskaya; Djamilja I Attoeva; Eugenii N Kukaev; Dmitriy Y Trofimov; Vladimir E Frankevich; Gennady T Sukhikh
Journal:  Metabolites       Date:  2022-05-31

4.  Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer.

Authors:  Woo Yeon Hwang; Dong Hoon Suh; Kidong Kim; Yong Beom Kim; Jae Hong No
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

5.  Prediction value with a novel and accurate tissue-based human papillomavirus detection method in low-grade squamous intraepithelial lesions.

Authors:  He Wang; Zheng He; Xue Han; Deyu Zhang; Shitai Zhang
Journal:  Cancer Med       Date:  2022-03-28       Impact factor: 4.711

6.  Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting.

Authors:  Phuong Lien Tran; Bruno Kenfack; Eveline Tincho Foguem; Manuela Viviano; Liliane Temogne; Pierre-Marie Tebeu; Rosa Catarino; Anne-Caroline Benski; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Womens Health       Date:  2017-12-01

7.  Human Papilloma Viruses and Their Genotype Distribution in Women with High Socioeconomic Status in Central Anatolia, Turkey: A Pilot Study.

Authors:  Mert Ulaş Barut; Engin Yildirim; Mehmet Kahraman; Murat Bozkurt; Necat Imirzalioğlu; Ayhan Kubar; Eray Çalişkan; Sibel Sak; Tarık Aksu
Journal:  Med Sci Monit       Date:  2018-01-04

8.  Prevalence of Abnormal Pap Smears: A Descriptive Study from a Cancer Center in a Low-Prevalence Community

Authors:  Bayan Maraqa; Isam Lataifeh; Lian Otay; Osama Badran; Yasar Qutaiba Nouri; Ibtihal Issam; Maysa Al Hussaini
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

9.  Comparison of Diagnostic Methods in Detection of Squamous Cell Abnormalities in Iranian Women with Abnormal Pap's Smear Test and Associated Demographic and Issues.

Authors:  Fatemeh Samiee Rad; Mahdi Ghaebi; Simin Zarabadipour; Arezoo Bajelan; Fatemeh Pashazade; Mehri Kalhor; Amane Barikani
Journal:  Iran J Pathol       Date:  2020-02-19

10.  The use of conization to identify and treat severe lesions among prediagnosed CIN1 and 2 patients in Japan.

Authors:  Mikio Mikami; Masae Ikeda; Hidetaka Sato; Haruko Iwase; Takayuki Enomoto; Yoichi Kobayashi; Hidetaka Katabuchi
Journal:  J Gynecol Oncol       Date:  2018-03-08       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.